Weight loss may result in improved pain, symptom severity, depression, and fibromyalgia scores in patients with obesity.
A large variability in the impact of physical activity on pain during acute migraine attacks was found in women who were overweight and obese.
Patients who are obese and experience knee pain were found to have improved pressure pain threshold at the patella and the wrist after weight loss associated with bariatric surgery vs medical management.
Special caution is warranted in the administration of pain treatment to patients with severe obesity, and additional research in this population is needed.
Weight loss was shown to decrease diffuse pain and symptom severity related to pain, with more reductions observed with greater weight loss.
Approximately 37% of US adults aged 60 years and older have been diagnosed with knee osteoarthritis, and the number is expected to rise.
Patients with hypothyroidism and obesity are more likely to experience lower oxygen saturation during sleep.
MRI was utilized to assessed cartilage degeneration in patients who lost weight over a 48-month period.
Obesity and sex are differential predictors of acute remission for commonly used antidepressant medications.
Obesity-related measures are not associated with the risk of developing chronic low-back pain.
Diabetes, prediabetes, and obesity may be metabolic drivers of polyneuropathy.
Even slight reductions in body weight can improve pain and mobility in patients with arthritis.
BMI related to pathogenesis of multi-site pain
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Examining the Efficacy of Different Oxygen Flow Rates for Cluster Headache Attacks
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds